Perspective
Alternatives to the QALY for Comparative Effectiveness Research
April 21, 2023
Featured Experts: Darius Lakdawalla, PhD, Charles E. Phelps, PhD
Research
All Research Featured Research
White Paper
Benefits of Medicare Coverage for Weight Loss Drugs
April 18, 2023
Featured Experts: Alison Sexton Ward, PhD, Bryan Tysinger, PhD, PhuongGiang Nguyen, MSPH, Dana Goldman, PhD, Darius Lakdawalla, PhD
Comment Letter
Comments to CMS on the Inflation Reduction Act’s Drug Price Negotiation Program
April 17, 2023
Featured Experts: Dana Goldman, PhD, Charles E. Phelps, PhD, Darius Lakdawalla, PhD, Joseph Grogan, JD, Karen Van Nuys, PhD, Barry Liden, JD, William Padula, PhD
White Paper
Mitigating the Inflation Reduction Act’s Adverse Impacts on the Prescription Drug Market
April 13, 2023
Featured Experts: Dana Goldman, PhD, Joseph Grogan, JD, Darius Lakdawalla, PhD, Barry Liden, JD, Erin Trish, PhD
Journal Article
The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Measuring the Value of Gains in Health: An Exact Formulation
April 3, 2023
Featured Experts: Darius Lakdawalla, PhD, Charles E. Phelps, PhD
Journal Article
Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D
March 18, 2023
Featured Experts: Darius Lakdawalla, PhD, Neeraj Sood, PhD
White Paper
Cancer-Related Technologies Have Changed a Lot. So Should Cancer Screening.
February 15, 2023
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, Karen Van Nuys, PhD
Journal Article
Methods to Adjust Willingness to Pay (WTP) Measures for Severity of Illness
February 14, 2023
Featured Experts: Charles E. Phelps, PhD, Darius Lakdawalla, PhD
White Paper
Price Changes Varied Widely Across California Hospital Systems from 2012 through 2018
August 18, 2022
Featured Experts: John Romley, PhD, Erin Trish, PhD, Darius Lakdawalla, PhD
Journal Article
Recommendations To Address Key Recruitment Challenges of Alzheimer’s Disease Clinical Trials
August 10, 2022
Featured Experts: Julie Zissimopoulos, PhD, Darius Lakdawalla, PhD, Desi Peneva, MS
Journal Article
Access to Disease-Modifying Alzheimer’s Therapies: Addressing Possible Challenges Using Innovative Payment Models
July 5, 2022
Featured Experts: Jakub Hlávka, PhD, Bryan Tysinger, PhD, Darius Lakdawalla, PhD
Comment Letter
Comments to the Federal Trade Commission on Pharmacy Benefit Managers
May 25, 2022
Featured Experts: Geoffrey Joyce, PhD, Darius Lakdawalla, PhD, Karen Mulligan, PhD, Neeraj Sood, PhD, Erin Trish, PhD, Karen Van Nuys, PhD
Journal Article
Impact of Non-Binding FDA Guidances On Primary Endpoint Selection in Alzheimer’s Disease Trials
March 24, 2022
Featured Experts: Jakub Hlávka, PhD, Darius Lakdawalla, PhD
Perspective
California Should Lead on Health Technology Assessment
January 27, 2022
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD
Perspective
How COVID Can Help Us Refocus on the How and Why of Value Assessment
October 21, 2021
Featured Experts: Darius Lakdawalla, PhD, Charles E. Phelps, PhD
Perspective
The Hidden Cost of Covid-19: Years of Life Lost Among the Young
October 14, 2021
Featured Experts: Darius Lakdawalla, PhD
White Paper
The Social Value of Disseminating Transcatheter Aortic Valve Replacement
September 28, 2021
Featured Experts: Duncan Ermini Leaf, PhD, Bryan Tysinger, PhD, Darius Lakdawalla, PhD
Perspective
Federal Government Should Advise on Drug Negotiations, Not Run Them
September 23, 2021
Featured Experts: Karen Mulligan, PhD, Darius Lakdawalla, PhD
Journal Article
Measuring the COVID-19 Mortality Burden in the United States
September 21, 2021
Featured Experts: Hanke Heun-Johnson, PhD, Bryan Tysinger, PhD, Darius Lakdawalla, PhD